[Ip-health] U.K. Labour Leader Jeremy Corbyn calls for use of compulsory licensing, public sector manufacturing and pricing controls on drugs using government funded inventions

Luis Gil Abinader luis.gil.abinader at keionline.org
Tue Sep 24 09:51:36 PDT 2019


Link: https://www.keionline.org/31723

Today, in his address to the U.K. Labour party conference, Labour Leader
Jeremy Corbyn made the following statement on drug patents and prices.

"Yesterday I met Luis Walker, a wonderful nine-year-old boy. Luis is living
with cystic fibrosis. Every day he needs at least four hours of treatment
and is often in hospital keeping him from school and his friends. Luis’
life could be very different with the aid of a medicine called Orkambi. But
Luis is denied the medicine he needs because its manufacturer refuses to
sell the drug to the NHS for an affordable price.

Luis, and tens of thousands of others suffering from illnesses such as
cystic fibrosis hepatitis C and breast cancer are being denied life-saving
medicines by a system that puts profits for shareholders before people’s
lives.

Labour will tackle this. We will redesign the system to serve public health
– not private wealth – using compulsory licensing to secure generic
versions of patented medicines. We’ll tell the drugs companies that if they
want public research funding then they’ll have to make their drugs
affordable for all. And we will create a new publicly owned generic drugs
manufacturer to supply cheaper medicines to our NHS saving our health
service money and saving lives. We are the party that created the NHS. Only
Labour can be trusted with its future."

His full remarks are available here:
https://labour.org.uk/press/jeremy-corbyns-labour-party-conference-leaders-address/

Just Treatment, a U.K. based patient group, has pushed for the government
to use its power under the Crown Use license provisions of the Patent Act,
to allow the National Health Service (NHS) to buy generic or biosimilar
versions of several drugs. Their most recent campaign involves the cystic
fibrosis drug Orkambi:
https://justtreatment.org/news/2019/2/1/time-for-plan-b-on-orkambi


More information about the Ip-health mailing list